The COMBO-UC trial project has been recommended for funding under Competition ABM/2022/3
We are very pleased to announce that the Project “Comparison of ustekinumab, infliximab and COMBinatiOn therapy in moderately-to-severely active Ulcerative Colitis – the head to head COMBO-UC trial” has been recommended for funding under the Competition ABM/2022/3 (Competition for non-commercial clinical trials or research experiments – head to head studies). Our Competition proposal received 131 […]